These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients. Kleemann T; Strauss M; Kouraki K; Zahn R Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746 [TBL] [Abstract][Full Text] [Related]
23. Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®. Russo AM; Wang Y; Al-Khatib SM; Curtis JP; Lampert R Pacing Clin Electrophysiol; 2013 Dec; 36(12):1522-31. PubMed ID: 23981009 [TBL] [Abstract][Full Text] [Related]
24. Defibrillation threshold testing during implantable cardioverter defibrillator implantation: 5-year follow-up. Kim SS; Park HW; Jeong HK; Lee KH; Yoon NS; Cho JG J Interv Card Electrophysiol; 2021 Apr; 60(3):485-491. PubMed ID: 32399866 [TBL] [Abstract][Full Text] [Related]
25. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? Russo AM; Sauer W; Gerstenfeld EP; Hsia HH; Lin D; Cooper JM; Dixit S; Verdino RJ; Nayak HM; Callans DJ; Patel V; Marchlinski FE Heart Rhythm; 2005 May; 2(5):456-61. PubMed ID: 15840466 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy. Yap SC; Schaer BA; Bhagwandien RE; Kühne M; Dabiri Abkenari L; Osswald S; Szili-Torok T; Sticherling C; Theuns DA Heart; 2014 Aug; 100(15):1188-92. PubMed ID: 24993502 [TBL] [Abstract][Full Text] [Related]
27. Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry. Steiner H; Geist M; Goldenberg I; Suleiman M; Glikson M; Tenenbaum A; Swissa M; Fisman EZ; Golovchiner G; Strasberg B; Barsheshet A; Cardiovasc Diabetol; 2016 Dec; 15(1):160. PubMed ID: 27905927 [TBL] [Abstract][Full Text] [Related]
28. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort. Heidbuchel H; Willems R; Jordaens L; Olshansky B; Carre F; Lozano IF; Wilhelm M; Müssigbrodt A; Huybrechts W; Morgan J; Anfinsen OG; Prior D; Mont L; Mairesse GH; Boveda S; Duru F; Kautzner J; Viskin S; Geelen P; Cygankiewicz I; Hoffmann E; Vandenberghe K; Cannom D; Lampert R Eur J Prev Cardiol; 2019 May; 26(7):764-775. PubMed ID: 30813818 [TBL] [Abstract][Full Text] [Related]
29. Assessment of Efficacy and Necessity of Routine Defibrillation Threshold Testing in Patients Undergoing Implantable Cardioverter-Defibrillator (ICD) Implantation. Ashino S; Nakai T; Sonoda K; Sasaki N; Kurokawa S; Ikeya Y; Okumura Y; Ohkubo K; Kunimoto S; Watanabe I; Hirayama A Int Heart J; 2015; 56(6):618-21. PubMed ID: 26549282 [TBL] [Abstract][Full Text] [Related]
30. Implantable Cardioverter Defibrillator Implantation with or Without Defibrillation Testing. Duffett S; El Hajjaji I; Manlucu J; Yee R Card Electrophysiol Clin; 2018 Mar; 10(1):119-125. PubMed ID: 29428133 [TBL] [Abstract][Full Text] [Related]
31. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion. Hadid C; Atienza F; Strasberg B; Arenal Á; Codner P; González-Torrecilla E; Datino T; Percal T; Almendral J; Ortiz M; Martins R; Martinez-Alzamora N; Fernandez Aviles F Cardiol J; 2015; 22(3):253-9. PubMed ID: 25179316 [TBL] [Abstract][Full Text] [Related]
32. The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. Bhavnani SP; Kluger J; Coleman CI; White CM; Guertin D; Shafi NA; Yarlagadda RK; Clyne CA Heart Rhythm; 2010 Jun; 7(6):755-60. PubMed ID: 20211275 [TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and outcomes of elderly patients treated with an implantable cardioverter-defibrillator or cardiac resynchronization therapy in a real-world setting: data from the Israeli ICD Registry. Suleiman M; Goldenberg I; Haim M; Schliamser JE; Boulos M; Ilan M; Swissa M; Gavrielov-Yusim N; Fuchs T; Amit G; Glikson M; Heart Rhythm; 2014 Mar; 11(3):435-41. PubMed ID: 24315966 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study. Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH; Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672 [TBL] [Abstract][Full Text] [Related]
39. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. Platonov PG; Haugaa KH; Bundgaard H; Svensson A; Gilljam T; Hansen J; Madsen T; Holst AG; Carlson J; Lie ØH; Kvistholm Jensen M; Edvardsen T; Jensen HK; Svendsen JH Am J Cardiol; 2019 Apr; 123(7):1156-1162. PubMed ID: 30678832 [TBL] [Abstract][Full Text] [Related]
40. Implantable Cardioverter-Defibrillator Placement for Primary Prevention in 2,346 Patients: Predictors of One-Year Survival. Merchant FM; Desai Y; Addish MA; Kelly K; Casey M; Goyal A; Leon AR; El-Chami MF Tex Heart Inst J; 2018 Aug; 45(4):221-225. PubMed ID: 30374229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]